Empagliflozin Medications

Empagliflozin Info

What Is Empagliflozin?

Empagliflozin belongs to a class of medicines called sodium-glucose co-transporter-2 (SGLT-2) inhibitors. Its main job is to help the body get rid of extra glucose (sugar) through the urine. In Hong Kong, empagliflozin is approved by the Medicines and Healthcare products Regulatory Authority (HK MHRA) for use in certain tablets, such as the combination product Glyxambi.

Which Medicines Contain Empagliflozin?

• Glyxambi - a fixed-dose tablet that combines empagliflozin with linagliptin. It is available in several strengths (e.g., 10 mg/5 mg, 25 mg/5 mg).
• Other empagliflozin-only tablets (e.g., Jardiance) are also approved in Hong Kong, but the focus here is on Glyxambi as the listed product.

These tablets come in film-coated solid form, meant to be swallowed whole with water. Generic versions may appear in the market, but the active content remains empagliflozin, sometimes paired with another active ingredient.

What Does Empagliflozin Treat?

• Type 2 diabetes - Empagliflozin helps lower blood glucose levels when diet and exercise are not enough on their own.
• Heart failure - Certain studies in Hong Kong have shown that adding empagliflozin can improve heart function in people with chronic heart failure.
• Kidney disease linked to diabetes - The drug may slow the decline of kidney function in patients with diabetic kidney disease.

These uses are based on the approvals granted by the HK MHRA. Doctors may prescribe empagliflozin as part of a broader treatment plan that includes other medicines, lifestyle changes, and regular monitoring.

How Does Empagliflozin Work?

Empagliflozin blocks the SGLT-2 proteins in the kidneys. These proteins normally re-absorb glucose back into the bloodstream. By inhibiting them, empagliflozin allows more glucose to leave the body in the urine, which reduces the amount of sugar circulating in the blood. This effect starts to appear within a few days after the first dose, but the full benefit may take a couple of weeks to become clear.

Safety Information

Common Side Effects

• Increased urination - Because more glucose leaves the body, you may notice you need to go to the bathroom more often.
• Mild genital or urinary discomfort - Some people report minor itching or irritation. Good personal hygiene can help reduce this.
• Thirst - The extra fluid loss may make you feel a little thirsty.

These effects are usually mild and tend to improve with continued use.

Serious Reactions

• Severe allergic reaction - Signs include swelling of the face, lips, or throat, and difficulty breathing. Seek emergency help if these occur.
• Ketoacidosis - Though rare, a serious buildup of acids in the blood can happen, especially if you are very ill or have a sudden change in diet. Look out for nausea, vomiting, abdominal pain, or breath that smells fruity.
• Low blood pressure - If you feel dizziness, fainting, or an unusually rapid heartbeat, contact a healthcare professional promptly.

Who Should Be Cautious

• Pregnant or breastfeeding women - Safety has not been established, so a doctor will weigh the benefits and risks.
• People with severe kidney problems - The drug relies on kidney function to work, so it may not be suitable if kidney function is markedly reduced.
• Individuals with a history of frequent urinary infections - Because empagliflozin increases urine glucose, infections may occur more often.

Interaction Awareness

• Other diabetes medicines - Using empagliflozin together with certain drugs may increase the risk of low blood sugar.
• Diuretics or blood pressure medicines - Combining these can lead to a greater drop in blood pressure.
• Alcohol - Drinking large amounts of alcohol can raise the chance of low blood sugar or dehydration.

For a full list of possible interactions, refer to the specific information that comes with each medication, such as Glyxambi.

What to Know Before Using

Store empagliflozin tablets in a cool, dry place away from direct sunlight. Do not keep them in the bathroom or near a kitchen sink. The usual treatment length can vary: some people take the medicine for a short period to improve blood sugar, while others may continue long-term for heart or kidney protection. Always follow the instructions that come with your particular product, as the dosage and duration may differ between empagliflozin-only tablets and combination medicines like Glyxambi.

For detailed usage, dosing, and administration, refer to the specific medication’s information sheet.

Key Terms

SGLT-2 inhibitor: A drug that reduces the re-absorption of glucose in the kidneys, helping lower blood sugar.

Combination tablet: A single pill that contains two different active ingredients, such as empagliflozin and linagliptin in Glyxambi.

Information Disclaimer

This article offers general educational information about empagliflozin as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing empagliflozin may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.